Free Trial

7 Best Stocks to Own Right Now

Today, we invite you to view our list of the seven best stocks to own for the next thirty days.

Why is it worth looking into these stocks? Some of Wall Street's most respected and most accurate research analysts have been upgrading these stocks and raising their price targets for these companies.

No, we're not talking recommendations from some no-name blogger or a junior analyst from a brokerage you've never heard of. These stocks have received multiple positive recommendations in the last 30 days from analysts that have received four-star and five-star rankings from MarketBeat's proprietary brokerage ranking system.

Analysts that earn rare four-star and five-star rankings from MarketBeat consistently issue accurate price targets, and their buy recommendations often outperform the market by double digits.

MarketBeat's editorial team has reviewed every research report published by these top-rated analysts in the last 90 days and have identified seven stocks that these analysts are poised for an immediate breakout.

#1 - Zscaler (NASDAQ:ZS)

Upgrades from Top-Ranked Analysts
10 (in the last 90 days)
Consensus Rating
Moderate Buy
Rating Score
2.8
Ratings Breakdown
28 Buy Ratings, 9 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$288.71 (3.7% Downside)

About Zscaler

Zscaler logoZscaler, Inc operates as a cloud security company worldwide. The company offers Zscaler Internet Access solution that provides users, workloads, IoT, and OT devices secure access to externally managed applications, including software-as-a-service (SaaS) applications and internet destinations; and Zscaler Private Access solution, which is designed to provide access to managed applications hosted internally in data centers, and private or public clouds. More about Zscaler
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
6/11/2025Cantor FitzgeraldBoost Price TargetOverweight ➝ Overweight$290.00 ➝ $340.00
6/9/2025Bank of AmericaBoost Price TargetBuy ➝ Buy$285.00 ➝ $340.00
6/6/2025ScotiabankBoost Price TargetSector Outperform ➝ Sector Outperform$310.00 ➝ $360.00
6/6/2025OppenheimerBoost Price TargetOutperform ➝ Outperform$290.00 ➝ $345.00
6/4/2025MizuhoBoost Price TargetNeutral ➝ Neutral$275.00 ➝ $290.00
6/4/2025BTIG ResearchBoost Price TargetBuy ➝ Buy$298.00 ➝ $329.00
6/2/2025Canaccord Genuity GroupSet Price TargetBuy ➝ Buy$230.00 ➝ $305.00
5/30/2025FBN SecuritiesUpgradeStrong-Buy
5/30/2025Loop CapitalBoost Price TargetHold ➝ Hold$250.00 ➝ $260.00
5/30/2025OppenheimerBoost Price TargetOutperform ➝ Outperform$250.00 ➝ $290.00

#2 - Kinross Gold (NYSE:KGC)

Upgrades from Top-Ranked Analysts
8 (in the last 90 days)
Consensus Rating
Moderate Buy
Rating Score
2.9
Ratings Breakdown
6 Buy Ratings, 3 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$15.40 (1.0% Upside)

About Kinross Gold

Kinross Gold logoKinross Gold Corporation, together with its subsidiaries, engages in the acquisition, exploration, and development of gold properties principally in the United States, Brazil, Chile, Canada, and Mauritania. The company operates the Fort Knox mine and the Manh Choh project in Alaska, as well as the Round Mountain and the Bald Mountain mines in Nevada, the United States; the Paracatu mine in Brazil; the La Coipa and the Lobo-Marte project in Chile; the Tasiast mine in Mauritania; and the Great Bear project in Canada. More about Kinross Gold
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
6/4/2025Royal Bank of CanadaBoost Price TargetSector Perform$14.00 ➝ $19.00
5/13/2025CIBCReiterated RatingOutperform ➝ Outperform
5/13/2025CIBCBoost Price TargetOutperformer ➝ Outperformer$14.00 ➝ $16.00
5/8/2025ScotiabankBoost Price TargetSector Outperform ➝ Sector Outperform$16.00 ➝ $17.00
4/23/2025National BanksharesReiterated RatingOutperform ➝ Outperform
4/16/2025BMO Capital MarketsInitiated CoverageOutperform
4/14/2025ScotiabankReiterated RatingOutperform ➝ Outperform
4/14/2025ScotiabankBoost Price TargetSector Outperform ➝ Sector Outperform$13.00 ➝ $16.00
4/4/2025Raymond JamesBoost Price TargetMarket Perform ➝ Market Perform$12.00 ➝ $15.00
3/21/2025National Bank FinancialUpgradeStrong-Buy

#3 - Microsoft (NASDAQ:MSFT)

Upgrades from Top-Ranked Analysts
8 (in the last 90 days)
Consensus Rating
Moderate Buy
Rating Score
2.9
Ratings Breakdown
29 Buy Ratings, 4 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$513.89 (8.7% Upside)

About Microsoft

Microsoft logoMicrosoft Corporation develops and supports software, services, devices and solutions worldwide. The Productivity and Business Processes segment offers office, exchange, SharePoint, Microsoft Teams, office 365 Security and Compliance, Microsoft viva, and Microsoft 365 copilot; and office consumer services, such as Microsoft 365 consumer subscriptions, Office licensed on-premises, and other office services. More about Microsoft
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
6/11/2025CitigroupBoost Price TargetBuy ➝ Buy$540.00 ➝ $605.00
6/4/2025Morgan StanleyReiterated RatingOverweight ➝ Overweight
5/23/2025Royal Bank of CanadaReiterated RatingOutperform ➝ Outperform$525.00
5/21/2025Piper SandlerReiterated RatingOverweight ➝ Overweight
5/21/2025BMO Capital MarketsReiterated RatingOutperform ➝ Outperform
5/21/2025Evercore ISISet Price TargetOutperform ➝ Outperform$500.00 ➝ $515.00
5/21/2025WedbushReiterated RatingOutperform ➝ Outperform
5/21/2025The Goldman Sachs GroupBoost Price TargetBuy ➝ Buy$480.00 ➝ $550.00
5/15/2025CitigroupBoost Price TargetBuy ➝ Buy$480.00 ➝ $540.00
5/1/2025Piper SandlerReiterated RatingNeutral ➝ Neutral

#4 - CMS Energy (NYSE:CMS)

Upgrades from Top-Ranked Analysts
7 (in the last 90 days)
Consensus Rating
Moderate Buy
Rating Score
2.6
Ratings Breakdown
7 Buy Ratings, 5 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$77.00 (10.1% Upside)

About CMS Energy

CMS Energy logoCMS Energy Corporation operates as an energy company primarily in Michigan. The company operates through three segments: Electric Utility; Gas Utility; and Enterprises. The Electric Utility segment is involved in the generation, purchase, transmission, distribution, and sale of electricity. This segment generates electricity through coal, wind, gas, renewable energy, oil, and nuclear sources. More about CMS Energy
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
5/22/2025Morgan StanleySet Price TargetEqual Weight ➝ Equal Weight$74.00 ➝ $71.00
4/29/2025BMO Capital MarketsBoost Price TargetOutperform ➝ Outperform$77.00 ➝ $79.00
4/28/2025Evercore ISIBoost Price TargetIn-Line ➝ In-Line$73.00 ➝ $76.00
4/25/2025ScotiabankReiterated RatingOutperform ➝ Outperform$77.00 ➝ $81.00
4/25/2025ScotiabankBoost Price TargetSector Outperform ➝ Sector Outperform$77.00 ➝ $81.00
4/25/2025Wells Fargo & CompanyBoost Price TargetOverweight ➝ Overweight$78.00 ➝ $82.00
4/23/2025Morgan StanleySet Price TargetOutperform ➝ Outperform$74.00
4/21/2025Jefferies Financial GroupBoost Price TargetBuy ➝ Buy$77.00 ➝ $83.00
4/14/2025BMO Capital MarketsLower Price TargetOutperform ➝ Outperform$80.00 ➝ $77.00
3/24/2025Bank of AmericaBoost Price TargetBuy ➝ Buy$73.00 ➝ $80.00

#5 - Alnylam Pharmaceuticals (NASDAQ:ALNY)

Upgrades from Top-Ranked Analysts
7 (in the last 90 days)
Consensus Rating
Moderate Buy
Rating Score
2.8
Ratings Breakdown
21 Buy Ratings, 4 Hold Ratings, 1 Sell Ratings.
Consensus Price Target
$319.17 (6.9% Upside)

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals logoAlnylam Pharmaceuticals, Inc, a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. Its marketed products include ONPATTRO (patisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; AMVUTTRA for the treatment of hATTR amyloidosis with polyneuropathy in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria; and OXLUMO for the treatment of primary hyperoxaluria type 1. More about Alnylam Pharmaceuticals
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
5/2/2025UBS GroupBoost Price TargetBuy ➝ Buy$331.00 ➝ $349.00
5/2/2025Chardan CapitalBoost Price TargetBuy ➝ Buy$300.00 ➝ $325.00
4/11/2025Morgan StanleyLower Price TargetEqual Weight ➝ Equal Weight$284.00 ➝ $268.00
4/9/2025Needham & Company LLCReiterated RatingBuy ➝ Buy$320.00 ➝ $320.00
4/2/2025HC WainwrightReiterated RatingBuy ➝ Buy$500.00 ➝ $500.00
3/31/2025ScotiabankBoost Price TargetSector Outperform ➝ Sector Outperform$338.00 ➝ $342.00
3/31/2025Redburn AtlanticInitiated CoverageBuy$353.00
3/31/2025Stifel NicolausBoost Price TargetBuy ➝ Buy$300.00 ➝ $345.00
3/24/2025JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$280.00 ➝ $328.00
3/21/2025CitigroupBoost Price TargetBuy ➝ Buy$338.00 ➝ $351.00

#6 - Darden Restaurants (NYSE:DRI)

Upgrades from Top-Ranked Analysts
6 (in the last 90 days)
Consensus Rating
Moderate Buy
Rating Score
2.6
Ratings Breakdown
17 Buy Ratings, 8 Hold Ratings, 1 Sell Ratings.
Consensus Price Target
$201.77 (7.2% Downside)

About Darden Restaurants

Darden Restaurants logoDarden Restaurants, Inc, together with its subsidiaries, owns and operates full-service restaurants in the United States and Canada. It operates under Olive Garden, LongHorn Steakhouse, Cheddar's Scratch Kitchen, Yard House, The Capital Grille, Seasons 52, Bahama Breeze, Eddie V's Prime Seafood, and Capital Burger brand names. More about Darden Restaurants
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
6/6/2025KeyCorpBoost Price TargetOverweight ➝ Overweight$220.00 ➝ $230.00
4/7/2025Robert W. BairdLower Price TargetNeutral ➝ Neutral$210.00 ➝ $192.00
3/24/2025GuggenheimBoost Price TargetBuy ➝ Buy$205.00 ➝ $220.00
3/21/2025Wells Fargo & CompanyBoost Price TargetEqual Weight ➝ Equal Weight$180.00 ➝ $200.00
3/21/2025CitigroupBoost Price TargetBuy ➝ Buy$223.00 ➝ $229.00
3/21/2025BarclaysBoost Price TargetOverweight ➝ Overweight$230.00 ➝ $235.00
3/21/2025UBS GroupBoost Price TargetBuy ➝ Buy$210.00 ➝ $225.00
3/21/2025KeyCorpBoost Price TargetOverweight ➝ Overweight$200.00 ➝ $220.00
3/21/2025BMO Capital MarketsBoost Price TargetMarket Perform ➝ Market Perform$175.00 ➝ $190.00
3/21/2025TD SecuritiesBoost Price TargetHold ➝ Hold$180.00 ➝ $190.00

#7 - Eversource Energy (NYSE:ES)

Upgrades from Top-Ranked Analysts
6 (in the last 90 days)
Consensus Rating
Hold
Rating Score
2.0
Ratings Breakdown
3 Buy Ratings, 4 Hold Ratings, 3 Sell Ratings.
Consensus Price Target
$65.78 (0.4% Upside)

About Eversource Energy

Eversource Energy logoEversource Energy, a public utility holding company, engages in the energy delivery business. The company operates through Electric Distribution, Electric Transmission, Natural Gas Distribution, and Water Distribution segments. It is involved in the transmission and distribution of electricity; solar power facilities; and distribution of natural gas. More about Eversource Energy
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
4/28/2025BMO Capital MarketsBoost Price TargetMarket Perform ➝ Market Perform$71.00 ➝ $72.00
4/10/2025JPMorgan Chase & Co.Reiterated RatingNeutral ➝ Underweight$69.00 ➝ $58.00
2/13/2025ScotiabankLower Price TargetSector Underperform ➝ Sector Underperform$56.00 ➝ $55.00
2/13/2025Wells Fargo & CompanyLower Price TargetOverweight ➝ Overweight$79.00 ➝ $75.00
2/10/2025GuggenheimReiterated RatingBuy ➝ Buy
1/28/2025Jefferies Financial GroupLower Price TargetUnderperform ➝ Underperform$52.00 ➝ $47.00
1/22/2025BarclaysLower Price TargetEqual Weight ➝ Equal Weight$72.00 ➝ $69.00
12/12/2024ScotiabankDowngradeSector Perform ➝ Sector Underperform$66.00 ➝ $56.00
12/3/2024Jefferies Financial GroupInitiated CoverageUnderperform$52.00
10/15/2024BarclaysBoost Price TargetEqual Weight ➝ Equal Weight$69.00 ➝ $72.00

More Investing Slideshows: